ATA751376A - Verfahren zur herstellung von 24,25-dihydroxy- cholesterinderivaten - Google Patents

Verfahren zur herstellung von 24,25-dihydroxy- cholesterinderivaten

Info

Publication number
ATA751376A
ATA751376A AT751376A AT751376A ATA751376A AT A751376 A ATA751376 A AT A751376A AT 751376 A AT751376 A AT 751376A AT 751376 A AT751376 A AT 751376A AT A751376 A ATA751376 A AT A751376A
Authority
AT
Austria
Prior art keywords
dihydroxycholesterol
derivatives
preparation
dihydroxycholesterol derivatives
Prior art date
Application number
AT751376A
Other languages
English (en)
Other versions
AT355236B (de
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/621,319 external-priority patent/US3994878A/en
Priority claimed from US05/623,859 external-priority patent/US4038272A/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ATA751376A publication Critical patent/ATA751376A/de
Priority to AT546479A priority Critical patent/AT361642B/de
Priority to AT0546379A priority patent/AT364099B/de
Priority to AT0546579A priority patent/AT364100B/de
Application granted granted Critical
Publication of AT355236B publication Critical patent/AT355236B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT751376A 1975-10-10 1976-10-08 Verfahren zur herstellung von 24,25-dihydroxy- cholesterinderivaten AT355236B (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AT546479A AT361642B (de) 1975-10-10 1979-08-10 Verfahren zur herstellung von neuen cholesterinderivaten
AT0546379A AT364099B (de) 1975-10-10 1979-08-10 Verfahren zur herstellung von neuen cholesterinderivaten
AT0546579A AT364100B (de) 1975-10-10 1979-08-10 Verfahren zur herstellung von neuen cholesterinderivaten

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/621,319 US3994878A (en) 1975-10-10 1975-10-10 Syntheses of 24R,25- and 24S,25-dihydroxycholesterol and alkanoyl derivatives thereof
US05/623,859 US4038272A (en) 1975-10-20 1975-10-20 Stereospecific syntheses of 24r,25- and 24s,25-dihydroxycholesterol and alkanoyl derivatives thereof

Publications (2)

Publication Number Publication Date
ATA751376A true ATA751376A (de) 1979-07-15
AT355236B AT355236B (de) 1980-02-25

Family

ID=27088923

Family Applications (1)

Application Number Title Priority Date Filing Date
AT751376A AT355236B (de) 1975-10-10 1976-10-08 Verfahren zur herstellung von 24,25-dihydroxy- cholesterinderivaten

Country Status (8)

Country Link
JP (1) JPS5246061A (de)
AT (1) AT355236B (de)
CH (1) CH628907A5 (de)
DE (1) DE2645527A1 (de)
FR (2) FR2407941A1 (de)
GB (5) GB1564806A (de)
IT (1) IT1068692B (de)
NL (1) NL7611155A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH644873A5 (de) * 1980-02-12 1984-08-31 Hoffmann La Roche Verfahren zur herstellung von cholesterinderivaten.
HUE062616T2 (hu) 2011-09-08 2023-11-28 Sage Therapeutics Inc Neuroaktív szteroidok, készítmények és alkalmazásaik
FI3932932T3 (fi) 2013-03-13 2025-10-15 Sage Therapeutics Inc Neuroaktiivisia steroideja ja niiden käyttömenetelmiä
PT3319611T (pt) 2015-07-06 2021-04-22 Sage Therapeutics Inc Oxisteróis e métodos de utilização dos mesmos
DK3812392T3 (da) 2015-07-06 2025-07-21 Sage Therapeutics Inc Oxysteroler og fremgangsmåder til anvendelse deraf
WO2017007832A1 (en) * 2015-07-06 2017-01-12 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
ES2921010T3 (es) 2016-04-01 2022-08-16 Sage Therapeutics Inc Oxisteroles y procedimientos de uso de los mismos
WO2017193046A1 (en) 2016-05-06 2017-11-09 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
WO2018009867A1 (en) 2016-07-07 2018-01-11 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
MA46351A (fr) 2016-09-30 2021-06-02 Sage Therapeutics Inc Oxystérols substitués en c7 et procédés en tant que modulateurs nmda
DK3529257T3 (da) 2016-10-18 2023-08-07 Sage Therapeutics Inc Oxysteroler og fremgangsmåder til anvendelse deraf

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7402846A (de) * 1973-03-02 1974-09-04
US3822254A (en) * 1973-05-21 1974-07-02 Hoffmann La Roche Synthesis of 25-hydroxycholesterol

Also Published As

Publication number Publication date
FR2407941A1 (fr) 1979-06-01
AT355236B (de) 1980-02-25
GB1564807A (en) 1980-04-16
DE2645527A1 (de) 1977-04-21
FR2407941B1 (de) 1980-05-16
GB1564810A (en) 1980-04-16
GB1564806A (en) 1980-04-16
JPS5246061A (en) 1977-04-12
CH628907A5 (en) 1982-03-31
GB1564809A (en) 1980-04-16
GB1564808A (en) 1980-04-16
NL7611155A (nl) 1977-04-13
FR2351998A1 (fr) 1977-12-16
FR2351998B1 (de) 1980-04-25
IT1068692B (it) 1985-03-21

Similar Documents

Publication Publication Date Title
AT333777B (de) Verfahren zur herstellung von 1,2-benzothiazin-3-carboxamiden
DD137225A5 (de) Verfahren zur herstellung von 1,2,4-triazin-5-on-derivaten
AT336613B (de) Verfahren zur herstellung von 2,2,6,6-tetramethyl-4-oxopiperidin
AT343802B (de) Verfahren zur herstellung von derivaten von 4,6-di-0- (aminoglycosyl)-2-deoxystreptaminen
AT338262B (de) Verfahren zur herstellung von 2,2,6,6-tetramethyl-4-oxopiperidin
AT352875B (de) Verfahren zur herstellung von neuen 4-oxa-1- azabicyclo-(3,2,0)heptan-7-onderivaten
DD129334A5 (de) Verfahren zur herstellung von 4-androsten-3,17-dion-derivaten
ATE3411T1 (de) Verfahren zur herstellung von 2,6dialkylcyclohexylaminen.
DD129326A5 (de) Verfahren zur herstellung von 1,4-diphenyl-3-pyrazolin-5-onen
AT338263B (de) Verfahren zur herstellung von 2,2,6,6-tetramethyl-4-oxopiperidin
AT355236B (de) Verfahren zur herstellung von 24,25-dihydroxy- cholesterinderivaten
DD136832A5 (de) Verfahren zur herstellung von 1,2-dichloraethan
AT346842B (de) Verfahren zur herstellung von 1,2-benz- isothiazolen
AT350558B (de) Verfahren zur herstellung von 2,4-dioxo- oxazolidinen
AT346852B (de) Verfahren zur herstellung von neuen derivaten des 1,2,4-oxadiazin-5-ons
DD132496A5 (de) Verfahren zur kontinuierlichen herstellung von 2,5-dioxo-1-oxa-2-phospholanen
AT352696B (de) Verfahren zur herstellung von cyclohexandion- (1,4)-tetramethyldiketal
DD134522A5 (de) Verfahren zur herstellung von 1,2,4-triazin-5-on-derivaten
DD132495A5 (de) Verfahren zur herstellung von 6a,10a-cis-hexahydrodibenzopyranonen
DD129333A5 (de) Verfahren zur herstellung von 4-androsten-3,17-dion-derivaten
AT347969B (de) Verfahren zur herstellung von 1-carbamoyl-3- (3,5-dichlorphenyl)-hydantoinen
DD128525A5 (de) Verfahren zur herstellung von 1,2,3,4-tetrahydro-4-oxo-(oder-oxy-)-1-naphthylharnstoffen
DD128359A5 (de) Verfahren zur herstellung von 5,6-dehydropenicillinen
ATA502076A (de) Verfahren zur herstellung von 6-acyloxy-4-methyl-hexa-2,4-dien-1-al
AT342074B (de) Verfahren zur herstellung von neuen derivaten des 1-hydroxybenzo-2,3,1-diazaborins

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee